Evolent Health (EVH) FCF Margin (2015 - 2026)

Evolent Health's FCF Margin history runs 12 years deep, the most recent figure standing at 1.49% for Q1 2026.

• In Q1 2026, FCF Margin fell 66.0% year-over-year to 1.49%; the TTM figure through Mar 2026 stood at 0.07% (up 48.0% YoY), while the FY2025 annual figure was 0.25%, up 49.0% from the prior year.
• FCF Margin was 1.49% for Q1 2026 at Evolent Health, down from 8.76% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 14.99% in Q4 2023 to a low of 22.2% in Q1 2022.
• Historically, FCF Margin has averaged 0.02% across 5 years, with a median of 0.07% in 2024.
• The sharpest annual moves came in 2022 and 2023: FCF Margin slumped 2099 bps in 2022, then surged 1822 bps in 2023.
• A 5-year view of FCF Margin shows it stood at 6.52% in 2022, then jumped by 130 bps to 14.99% in 2023, then plunged by 133 bps to 5.01% in 2024, then soared by 275 bps to 8.76% in 2025, then sank by 117 bps to 1.49% in 2026.
• The last three FCF Margin figures came in at 1.49% (Q1 2026), 8.76% (Q4 2025), and 1.43% (Q3 2025), per Business Quant data.